Applied DNA Sciences, Inc., based in Stony Brook, New York, specializes in producing and detecting DNA, employing 53 people and going public in 2001. The company develops PCR-based diagnostics for COVID-19 and uses its LinearDNA platform for DNA production in various markets, including in vitro diagnostics and anti-counterfeiting.
Applied Dna Sciences (APDN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Applied Dna Sciences's actual EPS was $0.47, beating the estimate of -$0.36 per share, resulting in a 231.65% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!